Antidiabetic drug causes double the weight loss of competitor in Type 2 diabetes patients

(University at Buffalo) Patients with Type 2 diabetes who were prescribed SGLT2 inhibitors lost more weight than patients who received GLP-1 receptor agonists, according to a University at Buffalo-led study.